Personal information

Activities

Collapse all

Employment (2)

University of Exeter: Exeter, Devon, GB

2015-01-01 to present | Associate Professor of Genomic Medicine and Sir Henry Dale Fellow (Medical School)
Employment
Source: Self-asserted source
Sarah Flanagan

University of Exeter: Exeter, Devon, GB

2007-01-01 to 2014-12-31 | Post-Doctoral Fellow (Medical School)
Employment
Source: Self-asserted source
Sarah Flanagan

Education and qualifications (2)

University of Bristol: Bristol, Bristol, GB

Education
Source: Self-asserted source
Sarah Flanagan

Peninsula College of Medicine and Dentistry: Exeter, GB

Education
Source: Self-asserted source
Sarah Flanagan

Professional activities (5)

University of Padua: Padua, Veneto, IT

G.B. Morgagni Medal
Distinction
Source: Self-asserted source
Sarah Flanagan

Genetics Society: London, GB

Membership
Source: Self-asserted source
Sarah Flanagan

Congenital Hyperinsulinism International : Glenn Ridge, New Jersey, US

2018-01-01 to present | Hyperinsulinism Global Registry Steering Committee Member
Service
Source: Self-asserted source
Sarah Flanagan

Genetics Society: London, GB

2014-01-01 to present | University of Exeter Local Representative
Service
Source: Self-asserted source
Sarah Flanagan

Genetics Society: London, GB

2020 | The Balfour Award
Distinction
Source: Self-asserted source
Sarah Flanagan

Funding (9)

Non-coding mutations in congenital hyperinsulinism: deciphering the role of gene dysregulation in human disease

2022-03-31 to 2027-03-30 | Grant
Wellcome Trust (London, UK, GB)
GRANT_NUMBER:

223187/Z/21/Z
Source: check_circle
WT Grant Tracker

Identifying novel insulin secretion disorders caused by mitochondrial dysfunction to highlight fundamental pathways within the β-cell

2021-10 to 2024-09 | Grant
Diabetes UK (London, GB)
Source: Self-asserted source
Sarah Flanagan

Novel insights into autoimmune diabetes

2020-07 to 2021-06 | Grant
Diabetes Research and Wellness Foundation (London, GB)
Source: Self-asserted source
Sarah Flanagan

Using state-of-the-art technology to discover novel genetic mechanisms of insulin secretion

2019-06 to 2020-05 | Grant
Northcott Devon Medical Foundation (Exeter, GB)
Source: Self-asserted source
Sarah Flanagan

Genetic Testing for Congenital Hyperinsulinism

2018-07 to 2021-12 | Grant
Congenital Hyperinsulinism International (Glen Ridge, New Jersey, US)
URL: https://congenitalhi.org/
Source: Self-asserted source
Sarah Flanagan

New insights into development and function of human β-cells by gene discovery in early-onset diabetes

2018-02 to 2019-01 | Grant
Diabetes Research and Wellness Foundation (London, GB)
Source: Self-asserted source
Sarah Flanagan

Single tube diagnosis and classification of diabetes

2015-08 to 2017-07 | Grant
Diabetes UK (London, GB)
Source: Self-asserted source
Sarah Flanagan

Applying the power of genetics to increase knowledge of underlying mechanisms of recessively inherited congenital hyperinsulinism.

2015-01-01 to 2019-12-31 | Grant
Wellcome Trust (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.4579312
GRANT_NUMBER:

105636/Z/14/Z
Source: Self-asserted source
Sarah Flanagan via DimensionsWizard

Liquid handling robot for studies defining novel genetic causes of neonatal diabetes and hyperinsulinism

2011-06-01 to 2014-05-31 | Grant
Diabetes UK (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.5149887
GRANT_NUMBER:

DUK-11/0004193
Source: Self-asserted source
Sarah Flanagan via DimensionsWizard

Peer review (2 reviews for 2 publications/grants)

Review activity for Acta diabetologica. (1)
Review activity for Journal of the Endocrine Society. (1)
How many people are using ORCID?